Jentadueto Xr Tablet, Film Coated, Extended Release
Product Images NDC 0597-0270

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Jentadueto Xr (NDC 0597-0270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Jentadueto 01

Jentadueto 01
FDA Label Image

Jentadueto 02

Jentadueto 02
FDA Label Image

Jentadueto 03

Jentadueto 03
FDA Label Image

Jentadueto 04

Jentadueto 04
FDA Label Image

Jentadueto 05

Jentadueto 05
This is a chart showing the number of patients at risk using the drugs Linagliptin and Glimepiride. The chart displays the number of patients for each drug at different time intervals over a period of 70 minutes. There is no additional information provided.*
FDA Label Image

Jentadueto 06

Jentadueto 06
FDA Label Image

Jentadueto 07

Jentadueto 07
Each tablet is a combination of 2.5 mg of linagliptin and 1000 mg of metformin hydrochloride. No dosage information is available in this text. The tablets must not be split, crushed, dissolved, or chewed. The medication guide should be dispensed with the tablets. The tablets may be stored at a temperature between 15°C to 30°C (59°F to 86°F). The medication should be kept away from children. The pharmaceutical product is distributed by BoehringerIngelheim Pharmaceuticals. The rest of the text is not readable.*
FDA Label Image

Jentadueto 08

Jentadueto 08
This text is a product label for Jentadueto XR, an extended-release tablet containing 5mg of linagliptin and 1000mg of metformin hydrochloride. The dosage instructions and storage guidelines are also outlined, along with cautionary information about administering the medicine to children. The label also includes information on the distributor and the trademark licensee, Boehringer Ingelheim.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.